Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Scott Rocklage Net Worth & Insider Trades

Scott Rocklage Audentes Therapeutics, Inc

As of April 26, 2017

What is Scott Rocklage's Net Worth?

The current estimated net worth of Audentes Therapeutics, Inc's Scott Rocklage is estimated to be about $260.19M . Scott Rocklage owns about 2,500,113 units of Audentes Therapeutics, Inc common stock. Recently at Audentes Therapeutics, Inc, Scott Rocklage has sold an estimated value of $0 worth.

What is Scott Rocklage's Past Insider Trading?

Scott Rocklage's largest purchase order was 172,413 units , worth over $2.5M on April 26, 2017. In total, Scott Rocklage has made about 1 transaction recently at Audentes Therapeutics, Inc. Scott Rocklage usually trades in April, with the busiest year in 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AM Partners III LLC, AM CoInvestors III LP, AM VENTURES III LP, JOHN DIEKMAN, Andrew J Schwab, SCOTT ROCKLAGE

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Scott Rocklage's' Mailing Address?

  • Mailing address is 179 Sandy Pond Road Lincoln MA 01773 MA

What are Audentes Therapeutics, Inc's Past Insider Trades?

Audentes Therapeutics, Inc's most recent insider trade came on December 27, 2019 by Louis Lange M.D., Ph.D. who sold 11,000 units worth $655.59K . In the last 3 years, insiders at Audentes Therapeutics, Inc have sold an estimated value of $142.4M and bought an estimated value of $15.46M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Matthew Patterson, Chief Executive Officer,  Louis G Lange, Director,  and Suyash Prasad, Senior VP & Chief Med Officer .

Audentes Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...